A2 Healthcare Corporation (“A2H”) is one of the leading Japanese CROs, with 1,400 employees in Tokyo, Osaka, and Taipei providing full CRO services in Japan and Taiwan. A2 is Medrio’s first Japanese Partner, having joined the Partner Program in 2014. They are also the first CRO in Japan to implement Medrio eSource in a clinical trial.
A2H has the capabilities and experience to support overseas clients from the early to late phases in any therapeutic area, as well as regulatory consultation and submission (Clinical Trial In-Country Care-taker services).
A2H is a subsidiary of Itochu Corporation, one of the largest Japanese companies. To learn more, please visit http://www.a2healthcare.com/en/.